DEF 14C: Inspire Veterinary Partners Stockholders Approve $30 Million Share Issuance to Tumim Stone Capital

Inspire Veterinary Partners' stockholders have approved the issuance of shares to Tumim Stone Capital LLC, potentially raising up to $30 million, to bolster working capital and for general corporate purposes.

Summary

• Inspire Veterinary Partners, Inc. has received stockholder approval for the issuance of shares to Tumim Stone Capital LLC, as outlined in a common stock purchase agreement dated November 30, 2023, and amended on January 19, 2024.
• The agreement allows Inspire to issue up to $30.0 million in Class A Common Stock (VWAP Shares) to Tumim, subject to certain conditions and limitations.
• As consideration for Tumim's commitment, Inspire issued 2,869,182 shares of Class A Common Stock (Commitment Shares) and a pre-funded warrant for 1,654,889 Warrant Shares.
• The purpose of the share issuance is to raise capital for working capital and general corporate purposes.
• The approval was obtained via written consent from the Majority Stockholders, holding 51.2% of the voting power, in lieu of a special meeting.
• The action becomes effective 20 days after the Information Statement is mailed to stockholders of record as of February 20, 2024.
• The company may not issue more than 1,214,293 VWAP Shares unless the average price of all shares is equal to or greater than $0.4954, or stockholder approval is obtained.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the capital injection is a positive, the dilution effect and reliance on this type of financing temper the overall outlook.

Positives

• The agreement provides Inspire with access to potential capital of up to $30.0 million.
• The funds are intended to be used for working capital and general corporate purposes, which could support growth initiatives.
• The company has secured the necessary stockholder approval to proceed with the share issuance.
• The Exchange Cap will not apply if the average price of all shares of Class A Common Stock purchased pursuant to the Purchase Agreement is equal to or greater than $0.4954.

Negatives

• The issuance of new shares will dilute existing stockholders' ownership.
• The company's reliance on this financing arrangement may indicate challenges in securing capital through other means.
• The actual amount of proceeds received will depend on market conditions and Inspire's discretion.
• The company may be obligated to pay Tumim a cash fee equal to $600,000 in lieu of issuing such shares of Class A Common Stock and Warrant Shares, under the terms and subject to the conditions described more fully in the Purchase Agreement, as amended.

Risks

• Market conditions and the trading price of Class A Common Stock could impact the amount of capital raised.
• The company's broad discretion over the use of proceeds introduces uncertainty for investors.
• Failure to meet certain conditions, such as maintaining the effectiveness of the resale registration statement, could impact the agreement.
• The company may be obligated to pay Tumim a cash fee equal to $600,000 in lieu of issuing such shares of Class A Common Stock and Warrant Shares, under the terms and subject to the conditions described more fully in the Purchase Agreement, as amended.

Future Outlook

Inspire expects that any proceeds received from sales to Tumim will be used for working capital and general corporate purposes; however, the actual sales of VWAP Shares to Tumim will depend on various factors, including market conditions and the trading price of the Class A Common Stock.

Management Comments

• The Information Statement is being delivered in lieu of notice of a meeting of stockholders pursuant to Section 78.320(3) of the Nevada Revised Statutes (the NRS).

Industry Context

Companies in the veterinary services industry often seek capital to fund expansion, acquisitions, or to improve their facilities and services; this agreement aligns with that trend.

Comparison to Industry Standards

• Similar agreements, such as private investments in public equity (PIPE) deals, are common in the small-cap market to raise capital quickly.
• The terms of the agreement, including the discount on VWAP and the issuance of commitment shares, are typical for this type of financing.
• Other companies in the veterinary space, such as Petco and Zoetis, rely on a mix of debt and equity financing to support their operations and growth.

Stakeholder Impact

• Existing shareholders will experience dilution of their ownership.
• The company's employees and customers may benefit from the increased financial stability and potential growth initiatives.
• The company's creditors may view the capital injection positively, as it strengthens the company's financial position.

Next Steps

• The action approved by written consent will become effective 20 calendar days after the Information Statement is first mailed to stockholders.
• Inspire may proceed with issuing VWAP Shares to Tumim, subject to the terms and conditions of the Purchase Agreement.
• Inspire intends to use the net proceeds from the share issuance for working capital and general corporate purposes.

Key Dates

Keywords

Inspire Veterinary Partners, Tumim Stone Capital, share issuance, stockholder approval, Class A Common Stock, VWAP Shares, Commitment Shares, financing, Nasdaq, dilution